Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 8 | 4 | 503-508
Tytuł artykułu

Neurophysiological evaluation in newly diagnosed Diabetes Mellitus type 1

Treść / Zawartość
Warianty tytułu
Języki publikacji
The aim of the study was to evaluate the effects of hyperglycemia on nerve conduction in patients with newly diagnosed diabetes mellitus type 1, and to investigate the significance of early electrophysiological diagnostics in these patients. The study included 85 newly disclosed patients with type 1 diabetes mellitus, in the first three months after the disease. Nerve conduction velocities (NCV) of further nerves were evaluated: median, peroneal, tibial and sural nerve as well as late responses (F-wave and H-reflex). Metabolic control parameters that were evaluated included: glycemia rate on the day of investigation and HbA1c. All patients had poor metabolic control parameters. We found NCV slowing predominantly in the tibial nerve (in 82.4% of patients). Prolonged F-wave latency was disclosed in 72.9% of patients, while H-reflex was evoked in 27.1% of patients only. The most sensitive parameter in the early neurophysiologic diagnostics was the measurement of F-wave latency. Our study underline the significance of early neurophysiological diagnosis, since hyperglycemia can play an acute role in NCV slowing, despite the absence of clinical symptoms, particularly in the first three months after the diagnosis has been confirmed.

Opis fizyczny
  • Cardiology Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Physical Medicine and Rehabilitation Department, University Children’s Hospital, Belgrade, Serbia
  • [1] Li Z., Hu X., Tang N., Significance of nueroelectrophysiological tests in the early diagnosis of sub-clinical neuropathay with diabetes mellitus, J. Huazhong Univ. Sci. Technolog. Med. Sci., 2006,26,429–431[Crossref]
  • [2] Karsidag S., Morali S., Sargin M., Salman S., Karsidag K., Us O., The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus, Diabetes Res. Clin. Pract., 2005, 67, 211–219[Crossref]
  • [3] Riiniama P., Souminen K., Tolonen U., Jantti V., Knip M., Tapanainem P., Peripheral nerve functions in increasingly impaired during puberty in adolescents with type 1 diabetes, Diabetes Care, 2001, 24, 1087–1092[Crossref]
  • [4] Charles M., Soedamah-Muthu S.S., Tesfaye S., Fuller J.H., Arezzo J.C., Chaturvedi N., et al., Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study, Diabetes Care, 2010, 33, 2648–2653[Crossref]
  • [5] Wright R.A., Nukada H., Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats, Brain, 1994, 117(Pt 6), 1395–1407[Crossref]
  • [6] Tesfaye S., Hariss J., Jakubowski J.J., Mody C., Wilson R.M., Rennie I.G., et al., Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography, Diabetologia, 1993, 36, 1266–1274[Crossref]
  • [7] Perkins B.A., Ngo M., Bril V., Symmetry of nerve conduction studies in different stage of diabetic polyneuropathy, Muscle Nerve, 2002, 25, 212–217[Crossref]
  • [8] Veves A., Malik R.A., Lye R.H., Masson E.A., Sharma A.K., Schady W., et al., The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy, Diabetic Medicine, 1991, 8, 917–921[Crossref]
  • [9] Malik R.A., Tesfaye S., Thompson S.D., Veves A., Sharma A.K., Boulton A.J., et al., Endoneural localization of microvascular damage in human diabetic neuropathy, Diabetologia, 1993, 36, 454–459[Crossref]
  • [10] American Diabetes Association., Diagnosis and classification of diabetes mellitus, Diabetes Care, 2010, 33, S62–S69[Crossref]
  • [11] Okada K., Osuga J., Kotani K., Yagyu H., Miyamoto M., Nagasaka S., et al., Current smoking status maybe associated with overt albuminuria in female patients with type 1 diabetes mellitus: a crosssectional study, Tob. Induc. Dis., 2012, 10, 12[Crossref]
  • [12] Albers J.W., Evaluation of the Patients with Suspected Peripheral Neuropathy, In: Pease W.S., Lew H.L., Johnson E.W., (Eds.), Johnson’s Practical Electromyography, 4th ed., Lippincott Wiliams & Wilkins, Philadelphia, 2007
  • [13] Fisher M.A., H reflexes and F waves. Fundamentals, normal and abnormal patterns, Neurol. Clin., 2002, 20, 339–360[Crossref]
  • [14] Rutkove S.B., Effects of temperature on neuromuscular electrophysiology, Muscle Nerve, 2001, 24, 867–882[Crossref]
  • [15] Fraser J.L., Olney R.K., The relative diagnostic sensitivity of different F-wave parameters in various polyneuropathies, Muscle Nerve, 1992, 15, 912–918[Crossref]
  • [16] Liu M.S., Hu B.L., Cui L.Y., Tang X.F., Du H., Li B.H., Clinical and neurophysiological features of 700 patients with diabetic peripheral neuropathy, Zhonghua Nei Ke Za Zhi, 2005;44:173–176
  • [17] Dyck P.J., O’Brien P.C., Litchy W.J., Harper C.M., Klein C.J., Dyck P.J., Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy, Diabetes Care, 2005, 28, 2192–2200[Crossref]
  • [18] Allen C., Duck S.C., Sufit R.L., Swick H.M., D’Alessio D.J., Glycemic control and peripheral nerve conduction in children and young adults after 5–6 mo of IDDM, Wisconsin DIABETES Registry, Diabetes Care, 1992, 15, 502–507[Crossref]
  • [19] Liu Q.Z., Pettitt D.J., Hanson R.L., Charles M.A., Klein R., Bennett P.H., et al., Glycated hemoglobin, plasma glucose and diabetic retinopathy: crosssectional and prospective analyses, Diabetologia, 1993, 36, 428–432 [Crossref]
  • [20] Jesic M., Sajic S., Jesic M., Kostic M., Peco-Antic A., Vujnovic Z., et al., Microalbuminuria in relation to metabolic control and blood pressure in adolescence with type 1 diabetes, Arch. Med. Sci., 2011, 7, 1037–1041[WoS][Crossref]
  • [21] Perkins B.A., Dholasania A., Buchanan R.A., Bril V., Short-term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1-year placebo cohort analysis, Diabet. Med., 2010, 27, 1271–1279[Crossref]
  • [22] Tesfaye S., Stevens L.K., Stephenson J.M., Fuller J.H., Plater M., Ionescu-Tirgoviste C., et al., Prevalence of diabetic peripheral neuropathy and its relations to glycemic controlled potential risk factors: The Eurodiab Type 1 Complications Study, Diabetologia, 1996, 39, 1377–1384[Crossref]
  • [23] Forrest K.Y., Maser R.E., Pambianco G., Becker D.J., Orchard T.J., Hypertension as a risk factor for diabetic neuropathy: a prospective study, Diabetes, 1997, 46, 665–670[Crossref]
  • [24] Adler A.I., Boyoko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Smith D.G., Risk factors for diabetic peripheral neuropathy; resultants of the Seattle Prospective Diabetes Foot Study, Diabetes Care, 1997, 20, 1162–1167[Crossref]
  • [25] Partanen J., Niskanen L., Lehtinen J., Mervaala E., Shtonen O., Uusitupa M., Natural history of peripheral neuropathy in patients with non-insulin-depended diabetes mellitus, N. Engl. J. Med., 1995, 333, 89–94[Crossref]
  • [26] Dyck P.J., Davies J.L., Wilson D.M., Service F.J., Melton L.J. 3rd., O’Brien P.C., Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort, Diabetes Care, 1999, 22, 1479–1486
  • [27] Tkac I., Bril V., Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy, Diabetes Care, 1998, 21, 1749–1752[Crossref]
  • [28] Lee S.S., Han H.S., Kim H., A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus, Pediatr. Diabetes, 2010, 11, 521–528[WoS]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.